Articles by Y Shimada (6)

Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma

S Komatsu, I Imoto, H Tsuda, K. i Kozaki, T Muramatsu, Y Shimada, S Aiko, Y Yoshizumi, D Ichikawa, E Otsuji and J. Inazawa

Carcinogenesis 30 ( 7 ): 1139 - 1146 , 2009

Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes

T Kohno, H Kunitoh, Y Shimada, K Shiraishi, Y Ishii, K Goto, Y Ohe, Y Nishiwaki, A Kuchiba, S Yamamoto, H Hirose, A Oka, N Yanagitani, R Saito, H Inoko and J. Yokota

Carcinogenesis 31 ( 5 ): 834 - 841 , 2010

Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs

T Kohno, R Kakinuma, M Iwasaki, T Yamaji, H Kunitoh, K Suzuki, Y Shimada, K Shiraishi, Y Kasuga, G. S Hamada, K Furuta, K Tsuta, H Sakamoto, A Kuchiba, S Yamamoto, Y Kanai, S Tsugane and J. Yokota

Carcinogenesis 31 ( 10 ): 1794 - 1799 , 2010

A Randomized Phase II/III Trial Comparing Hepatectomy Followed by mFOLFOX6 with Hepatectomy Alone as Treatment for Liver Metastasis from Colorectal Cancer: Japan Clinical Oncology Group Study JCOG0603

Y Kanemitsu, T Kato, Y Shimizu, Y Inaba, Y Shimada, K Nakamura, A Sato, Y Moriya and for the Colorectal Cancer Study Group (CCSG) of Japan Clinical Oncology Group

Japanese Journal of Clinical Oncology 39 ( 6 ): 406 - 409 , 2009

Vascular Endothelial Growth Factor Receptor Expression as a Prognostic Marker for Survival in Colorectal Cancer

N. T Okita, Y Yamada, D Takahari, Y Hirashima, J Matsubara, K Kato, T Hamaguchi, K Shirao, Y Shimada, H Taniguchi and T. Shimoda

Japanese Journal of Clinical Oncology 39 ( 9 ): 595 - 600 , 2009

Pfetin as a Prognostic Biomarker in Gastrointestinal Stromal Tumor: Novel Monoclonal Antibody and External Validation Study in Multiple Clinical Facilities

K Kikuta, M Gotoh, T Kanda, N Tochigi, T Shimoda, T Hasegawa, H Katai, Y Shimada, Y Suehara, A Kawai, S Hirohashi and T. Kondo

Japanese Journal of Clinical Oncology 40 ( 1 ): 60 - 72 , 2010